Pharmacokinetic interaction between diltiazem and morin, a flavonoid, in rats

Pharmacological Research

Volumn 52, Issue 5, 2005, Pages 386-391

  Choi, Jun Shik ^a   Han, Hyo Kyung ^a  

^a Chosun University   (South Korea)

Author keywords

Desacetyldiltiazem; Diltiazem; Morin; Pharmacokinetics; Rat

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CYTOCHROME P450 3A4; DEACETYLDILTIAZEM; DILTIAZEM; DRUG METABOLITE; FLAVONOID; MORIN;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG HALF LIFE; DRUG METABOLISM; DRUG POTENTIATION; ENZYME INHIBITION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; AREA UNDER CURVE; CYTOCHROME P-450 ENZYME SYSTEM; DILTIAZEM; DRUG INTERACTIONS; FLAVONOIDS; MALE; P-GLYCOPROTEIN; RATS; RATS, SPRAGUE-DAWLEY;

EID: 27444441306     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2005.05.011     Document Type: Article

References (35)

1. M. Chaffman, and R.N. Brogden Diltiazem: a review of its pharmacological properties and therapeutic efficacy Drugs 29 1985 387 454
2. M.R. Weir Diltiazem: ten years of clinical experience in the treatment of hypertension J Clin Pharmacol 35 1995 220 232
3. P.K. Yeung, C. Prescott, C. Haddad, T.J. Montague, C. McGregor, and M.A. Quilliam Pharmacokinetics and metabolism of diltiazem in healthy males and females following a single oral dose Eur J Drug Metab Pharmacokinet 18 1993 199 206
4. M.M.-T. Buckley, S.M. Grant, K.L. Goa, D. McTabish, and E.M. Sorkin Diltiazem: a reappraisal of its pharmacological properties and therapeutic use Drugs 39 1990 757 806
5. H. Narita, M. Otsuka, H. Yabana, and T. Nagao Hypotensive response of spontaneously hypertensive rats to centrally administered diltiazem and its metabolites: in relevance to the hypotensive action by oral administration J Pharmacobiodyn 9 1986 547 553
6. P.K. Yeung, J.D.Z. Feng, and S.J. Buckley Pharmacokinetics and hypotensive effect of diltiazem in rabbits: comparison of diltiazem with its major metabolites J Pharm Pharmacol 50 1998 1247 1253
7. L. Pichard, G. Gillet, I. Fabre, I. Dalet-Beluche, C. Bonfils, and J.P. Thenot Identification of the rabbit and human cytochromes P-450IIIA as the major enzymes involved in the N-demethylation of diltiazem Drug Metab Dispos 18 1990 711 719
8. P.B. Watkins, S.A. Wrighton, E.G. Schuetz, D.T. Molowa, and P.S. Guzelian Identification of glucocorticoid-inducible cytochromes P-450 in the intestinal mucosa of rats and man J Clin Invest 80 1987 1029 1036
9. J.C. Kolars, P. Schmiedlin-Ren, W.O. Dobbins, J. Schuetz, S.A. Wrighton, and P.B. Watkins Heterogeneity of cytochrome P450IIIA expression in rat gut epithelia Gastroenterology 102 1992 1186 1198
10. M. Lefebvre, W. Homsy, G. Caille, and P. du Souich First-pass metabolism of diltiazem in anesthetized rabbits: role of extrahepatic organs Pharm Res 13 1996 124 128
11. W. Homsy, G. Caille, and P. du Souich The site of absorption in the small intestine determines diltiazem bioavailability in the rabbit Pharm Res 12 1995 1722 1726
12. W. Homsy, M. Lefebvre, G. Caille, and P. du Souich Metabolism of diltiazem in hepatic and extrahepatic tissues of rabbits: in vitro studies Pharm Res 12 1995 609 614
13. Y.H. Lee, M.H. Lee, and C.K. Shim Pharmacokinetics of diltiazem and deacetyldiltiazem in rats Int J Pharm 76 1991 71 76
14. K. Yusa, and T. Tsuruo Reversal mechanism of multidrug resistance by verapamil: direct binding of verapamil to P-glycoprotein on specific sites and transport of verapamil outward across the plasma membrane of K562/ADM cells Cancer Res 49 1989 5002 5006
15. V.J. Wacher, L. Salphati, and L.Z. Benet Active secretion and enterocytic drug metabolism barriers to drug absorption Adv Drug Deliv Rev 46 2001 89 102
16. M.M. Gottesman, and I. Pastan Biochemistry of multidrug resistance mediated by the multidrug transporter Annu Rev Biochem 62 1993 385 427
17. L.S.L. Gan, M.A. Moseley, B. Khosla, P.F. Augustijns, T.P. Bradshaw, and R.W. Hendren CYP3A-Like cytochrome P450-mediated metabolism and polarized efflux of cyclosporin A in Caco-2 cells: interaction between the two biochemical barriers to intestinal transport Drug Metab Dispos 24 1996 344 349
18. V.H. Wacher, J.A. Silverman, Y. Zhang, and L.Z. Benet Role of P-glycoprotein and cytochrome P450 3A in limiting oral absorption of peptides and peptidomimetics J Pharm Sci 87 1998 1322 1330
19. K. Ito, H. Kusuhara, and Y. Sugiyama Effects of intestinal CYP3A4 and P-glycoprotein on oral drug absorption theoretical approach Pharm Res 16 1999 225 231
20. R.A. Dixon, and C.L. Steele Flavonoids and isoflavonoids - a gold mine for metabolic engineering Trends Plant Sci 4 1999 394 400
21. Y. Hanasaki, S. Ogawa, and S. Fukui The correlation between active oxygens scavenging and antioxidative effects of flavonoids Free Radic Biol Med 16 1994 845 850
22. A.R. Francis, T.K. Shetty, and R.K. Bhattacharya Modulating effect of plant flavonoids on the mutagenicity of N-methyl-N′-nitro-N- nitrosoguanidine Carcinogenesis 10 1989 1953 1955
23. S.H. Fang, Y.C. Hou, W.C. Chang, S.L. Hsiu, P-D.L. Chao, and B.L. Chiang Morin sulfates/glucuronides exert anti-inflammatory activity on activated macrophages and decreased the incidence of septic shock Life Sci 74 2003 743 756
24. P. Hodek, P. Trefil, and M. Stiborova Flavonoids-potent and versatile biologically active compounds interacting with cytochromes P450 Chem Biol Interact 139 2002 1 21
25. S. Zhang, and M.E. Morris Effects of the flavonoids biochanin A, morin, phloretin, and silymarin on P-glycoprotein-mediated transport J Pharmacol Exp Ther 304 2003 1258 1267
26. P.K.F. Yeung, S.J. Mosher, M.A. Quilliam, and T.J. Montague Species comparison of pharmacokinetics and metabolism of diltiazem in humans, dogs, rabbits, and rats Drug Metab Dispos 18 1990 1055 1059
27. K.J. Goebel, and E.U. Kolle High performance liquid chromatographic determination of diltiazem and four of its metabolites in plasma J Chromatogr 345 1985 355 363
28. L.Z. Benet, C.L. Cummins, and C.Y. Wu Transporter-enzyme interactions: implications for predicting drug-drug interactions from in vitro data Curr Drug Metab 4 2003 393 398
29. C.L. Cummins, W. Jacobsen, and L.Z. Benet Unmasking the dynamic interplay between intestinal P-glycoprotein and CYP3A4 J Pharmacol Exp Ther 300 2002 1036 1045
30. T. Saeki, K. Ueda, Y. Tanigawara, R. Hori, and T. Komano P-glycoprotein-mediated transcellular transport of MDR-reversing agents FEBS Lett 324 1993 99 102
31. Y.C. Hou, P.D.L. Chao, H.J. Ho, C.C. Wen, and S.L. Hsiu Profound difference in pharmacokinetics between morin and its isomer quercetin in rats J Pharm Pharmacol 55 2003 199 203
32. J.S. Choi, B.W. Jo, and Y.C. Kim Enhanced paclitaxel bioavailability after oral administration of paclitaxel or prodrug to rats pretreated with quercetin Eur J Pharm Biopharm 57 2004 313 318
33. J.S. Choi, and H.K. Han The effect of quercetin on the pharmacokinetics of verapamil and its major metabolite, norverapamil, in rabbits J Pharm Pharmacol 56 2004 1537 1542
34. S.L. Hsiu, Y.C. Hou, Y.H. Wang, C.W. Tsao, S.F. Su, and P.-D.L. Chao Quercetin significantly decreased cyclosporin oral bioavailability in pigs and rats Life Sci 72 2002 227 235
35. J. Dupuy, G. Larrieu, J.F. Sutra, A. Lespine, and M. Alvinerie Enhancement of moxidectin bioavailability in lamb by a natural flavonoid: quercetin Vet Parasitol 112 2003 337 347